BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2116 related articles for article (PubMed ID: 30308479)

  • 21. Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
    Tang H; Wang Z; Shao Q; Wang Y; Yang Q
    Med Sci Monit; 2020 Jun; 26():e922676. PubMed ID: 32533823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
    Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
    Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using RNA sequencing to identify a putative lncRNA-associated ceRNA network in laryngeal squamous cell carcinoma.
    Lyu K; Li Y; Xu Y; Yue H; Wen Y; Liu T; Chen S; Liu Q; Yang W; Zhu X; Wang Z; Chai L; Wen W; Li C; Lei W
    RNA Biol; 2020 Jul; 17(7):977-989. PubMed ID: 32174248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma.
    Yang Y; Feng L; Wang R; Ma H; He S; Fang J
    Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
    Wang H; Niu L; Jiang S; Zhai J; Wang P; Kong F; Jin X
    Oncotarget; 2016 Dec; 7(52):86174-86185. PubMed ID: 27863388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour.
    Tang F; Lu Z; Wang J; Li Z; Wu W; Duan H; He Z
    BMC Med Genomics; 2019 Dec; 12(1):194. PubMed ID: 31842887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
    Zhou D; Gao B; Yang Q; Kong Y; Wang W
    Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer.
    Li G; Han L; Ren F; Zhang R; Qin G
    J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
    Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H
    J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
    Li F; Huang C; Li Q; Wu X
    Med Sci Monit; 2018 Jan; 24():37-49. PubMed ID: 29295970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
    Chen P; Zhang W; Chen Y; Zheng X; Yang D
    Mol Med Rep; 2020 Jul; 22(1):405-415. PubMed ID: 32377727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of the LncRNAs, MiRNAs, and MRNAs acting within the competing endogenous RNA network of LGG.
    Ding Y; Liu H; Zhang C; Bao Z; Yu S
    Genetica; 2022 Feb; 150(1):41-50. PubMed ID: 34993720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 106.